이 애플리케이션의 일부 콘텐츠는 현재 사용할 수 없습니다.
이 상황이 계속되면 다음 주소로 문의하십시오피드백 및 연락
1. (WO2010123933) COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING 1,3,4-OXADIAZOLE DERIVATIVES
국제사무국에 기록된 최신 서지정보   

공개번호: WO/2010/123933 국제출원번호: PCT/US2010/031798
공개일: 28.10.2010 국제출원일: 20.04.2010
IPC:
A61K 31/41 (2006.01)
A SECTION A — 생활필수품 농업
61
위생학; 의학 또는 수의학
K
의약용, 치과용 또는 화장용 제제
31
유기 활성 성분을 함유 하는 의약품 제재
33
이종 환식화합물
395
이종 환원자로서 질소가 있는 것, 예. 구아네티딘, 리파마이신
41
2개 또는 그 이상의 이종환원자가 있고, 그중 적어도 1개는 질소인 5원환이 있는 것, 예. 테트라졸
출원인:
RUSSELL, Michael Geoffrey Neil [GB/GB]; GB (UsOnly)
DOYLE, Kevin James [GB/GB]; GB (UsOnly)
INSTITUTE FOR ONEWORLD HEALTH [US/US]; 280 Utah Avenue, Suite 250 South San Francisco, California 94080, US (AllExceptUS)
발명자:
RUSSELL, Michael Geoffrey Neil; GB
DOYLE, Kevin James; GB
대리인:
KONSKI, Antoinette F.; FOLEY & LARDNER LLP 975 Page Mill Road Palo Alto, California 94304-1013, US
우선권 정보:
61/171,05620.04.2009US
발명의 명칭: (EN) COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING 1,3,4-OXADIAZOLE DERIVATIVES
(FR) COMPOSÉS, COMPOSITIONS ET MÉTHODES COMPRENANT DES DÉRIVÉS DU 1,3,4-OXADIAZOLE
요약서:
(EN) The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-2 or encompassed by formulas I-IV) or compositions comprising these compounds, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.
(FR) La présente invention porte sur des compositions et des méthodes pour traiter une maladie chez un animal, la maladie étant sensible à l'inhibition du polypeptide régulateur de la conductance transmembranaire de mucoviscidose (CFTR) fonctionnel par administration, à un mammifère qui en a besoin, d'une quantité efficace d'un composé défini dans la présente invention (comprenant les composés présentés dans les Tableaux 1-2 ou englobés par les formules I à IV) ou de compositions comprenant ces composés, permettant ainsi de traiter la maladie. La présente invention concerne en particulier une méthode de traitement de la diarrhée et de la maladie polykystique des reins.
front page image
지정국: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
아프리카지역 지식재산권기구(ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
유라시아 특허청 (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
유럽 특허청(EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
공개언어: 영어 (EN)
출원언어: 영어 (EN)